State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, 250012, Jinan, Shandong, China.
National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, 250012, Jinan, Shandong, China.
Cardiovasc Diabetol. 2024 May 7;23(1):160. doi: 10.1186/s12933-024-02258-3.
Diabetic cardiomyopathy (DCM) is a crucial complication of long-term chronic diabetes that can lead to myocardial hypertrophy, myocardial fibrosis, and heart failure. There is increasing evidence that DCM is associated with pyroptosis, a form of inflammation-related programmed cell death. Growth differentiation factor 11 (GDF11) is a member of the transforming growth factor β superfamily, which regulates oxidative stress, inflammation, and cell survival to mitigate myocardial hypertrophy, myocardial infarction, and vascular injury. However, the role of GDF11 in regulating pyroptosis in DCM remains to be elucidated. This research aims to investigate the role of GDF11 in regulating pyroptosis in DCM and the related mechanism.
Mice were injected with streptozotocin (STZ) to induce a diabetes model. H9c2 cardiomyocytes were cultured in high glucose (50 mM) to establish an in vitro model of diabetes. C57BL/6J mice were preinjected with adeno-associated virus 9 (AAV9) intravenously via the tail vein to specifically overexpress myocardial GDF11. GDF11 attenuated pyroptosis in H9c2 cardiomyocytes after high-glucose treatment. In diabetic mice, GDF11 alleviated cardiomyocyte pyroptosis, reduced myocardial fibrosis, and improved cardiac function. Mechanistically, GDF11 inhibited pyroptosis by preventing inflammasome activation. GDF11 achieved this by specifically binding to apoptosis-associated speck-like protein containing a CARD (ASC) and preventing the assembly and activation of the inflammasome. Additionally, the expression of GDF11 during pyroptosis was regulated by peroxisome proliferator-activated receptor α (PPARα).
These findings demonstrate that GDF11 can treat diabetic cardiomyopathy by alleviating pyroptosis and reveal the role of the PPARα-GDF11-ASC pathway in DCM, providing ideas for new strategies for cardioprotection.
糖尿病心肌病(DCM)是长期慢性糖尿病的一个重要并发症,可导致心肌肥大、心肌纤维化和心力衰竭。越来越多的证据表明,DCM 与细胞焦亡有关,细胞焦亡是一种与炎症相关的程序性细胞死亡形式。生长分化因子 11(GDF11)是转化生长因子-β超家族的一员,可调节氧化应激、炎症和细胞存活,从而减轻心肌肥大、心肌梗死和血管损伤。然而,GDF11 在调节 DCM 中细胞焦亡的作用仍有待阐明。本研究旨在探讨 GDF11 在调节 DCM 中细胞焦亡的作用及其相关机制。
通过尾静脉注射链脲佐菌素(STZ)诱导小鼠糖尿病模型,培养高糖(50 mM)条件下的 H9c2 心肌细胞建立体外糖尿病模型。通过尾静脉静脉内注射腺相关病毒 9(AAV9)预先注射 C57BL/6J 小鼠,特异性过表达心肌 GDF11。GDF11 减轻高糖处理后 H9c2 心肌细胞的细胞焦亡。在糖尿病小鼠中,GDF11 减轻心肌细胞焦亡,减少心肌纤维化,改善心功能。机制上,GDF11 通过抑制炎症小体激活来抑制细胞焦亡。GDF11 通过特异性结合含有 CARD 的凋亡相关斑点样蛋白(ASC)并阻止炎症小体的组装和激活来实现这一点。此外,GDF11 在细胞焦亡过程中的表达受过氧化物酶体增殖物激活受体 α(PPARα)调节。
这些发现表明,GDF11 通过减轻细胞焦亡来治疗糖尿病心肌病,并揭示了 PPARα-GDF11-ASC 通路在 DCM 中的作用,为心脏保护的新策略提供了思路。